Celldex Therapeutics

IPO

Celldex Therapeutics is a biotech company in HAMPTON, United States, founded in 1983. It has raised $300.0M across 1 round, most recently a $300.0M Venture Round in March 2024.

Pioneering new horizons in immunology

Employees
51–200
Founded
1983
Business Model
B2B
Total Funding
$300.0M
Last Round
$300.0M Venture RoundMar 2024
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

Celldex Therapeutics is a clinical-stage biopharmaceutical company pioneering novel antibody-based treatments that engage the human immune system to improve the lives of patients with allergic, inflammatory, and autoimmune disorders. Originally founded in 1983 as AVANT Immunotherapeutics and renamed Celldex Therapeutics in 2008 following a merger with private Celldex Therapeutics Inc., the company is headquartered in Hampton, New Jersey. Celldex focuses on advancing mast cell biology and developing therapeutic antibodies targeting conditions such as urticaria, atopic dermatitis, and other immunological diseases. The company is publicly traded on Nasdaq under the ticker symbol CLDX.

Summary

It lists 51–200 employees. It has raised $300.0M in total across 1 round, most recently a $300.0M Venture Round in Mar 2024.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Venture RoundVenture RoundMar 2024
$300.0M

Sign up to see all 2 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Celldex Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/celldex-therapeutics"><img src="https://indexed.vc/api/badge/company/celldex-therapeutics" alt="Celldex Therapeutics on Indexed.vc" width="260" height="76" /></a>